- Home
- CYTO vs BACK Comparison
CYTO vs BACK Comparison
Compare CYTO & BACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTO
- BACK
- Stock Information
- Founded
- CYTO 2003
- BACK 2000
- Country
- CYTO Bermuda
- BACK United States
- Employees
- CYTO N/A
- BACK N/A
- Industry
- CYTO Biotechnology: Pharmaceutical Preparations
- BACK Medical Specialities
- Sector
- CYTO Health Care
- BACK Health Care
- Exchange
- CYTO Nasdaq
- BACK Nasdaq
- Market Cap
- CYTO 2.0M
- BACK 2.2M
- IPO Year
- CYTO N/A
- BACK 2019
- Fundamental
- Price
- CYTO $0.41
- BACK $1.10
- Analyst Decision
- CYTO
- BACK
- Analyst Count
- CYTO 0
- BACK 0
- Target Price
- CYTO N/A
- BACK N/A
- AVG Volume (30 Days)
- CYTO 182.2K
- BACK 23.2K
- Earning Date
- CYTO 09-24-2024
- BACK 12-31-2024
- Dividend Yield
- CYTO N/A
- BACK N/A
- EPS Growth
- CYTO N/A
- BACK N/A
- EPS
- CYTO N/A
- BACK N/A
- Revenue
- CYTO N/A
- BACK N/A
- Revenue This Year
- CYTO N/A
- BACK N/A
- Revenue Next Year
- CYTO N/A
- BACK N/A
- P/E Ratio
- CYTO N/A
- BACK N/A
- Revenue Growth
- CYTO N/A
- BACK N/A
- 52 Week Low
- CYTO $0.40
- BACK $0.98
- 52 Week High
- CYTO $3.60
- BACK $7.75
- Technical
- Relative Strength Index (RSI)
- CYTO 43.48
- BACK 45.18
- Support Level
- CYTO $0.40
- BACK $1.06
- Resistance Level
- CYTO $0.58
- BACK $1.21
- Average True Range (ATR)
- CYTO 0.06
- BACK 0.10
- MACD
- CYTO 0.00
- BACK 0.01
- Stochastic Oscillator
- CYTO 17.14
- BACK 29.17
About CYTO Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.
About BACK IMAC Holdings Inc.
IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.